PERRIN STEVEN (See Remarks) received a stock award from ELEDON PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/4/2026ACC: 0001193125-26-333133
DirectorOfficer· See Remarks
Since Sep 2020
+80.22K
Net shares
Net buyer
$243.8K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
152.35K acquired · 72.14K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+152.35K
Price / share
—
Trade value
—
% of position
15235.3%
7/31/2026
1K→153.35K
Common Stock
Direct
Shares
−72.14K
Price / share
$3.38
Trade value
$243.83K
% of position
47.0%
7/31/2026
153.35K→81.22K
Total
Net shares
+80.22K
Net value
-$243.83K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/31/2026 | A · Award | +152.35K | — | — | 15235.3% | 1K | 153.35K |
| Common Stock Direct | 7/31/2026 | F · Tax Withholding | −72.14K | $3.38 | $243.83K | 47.0% | 153.35K | 81.22K |
| Total | +80.22K | -$243.83K | ||||||
Derivative Transactions0
No derivative transactions reported